Following the brand launch a year ago, CPHI 2026 marks a perfect opportunity for many customers to meet Codis, the newly launched global CDMO combining materials characterisation and formulation development expertise in Nottingham, UK, scale-up and commercial spray drying operations in Haverhill, UK, and particle engineering capabilities in the United States.
Codis brings together decades of scientific, technical development/ scale-up and commercial manufacturing experience under one brand. The company supports pharmaceutical, consumer health and nutraceutical customers with a broad range of development and manufacturing solutions, helping products progress from early-stage development through to commercial supply.
In the UK, Codis combines complementary capabilities across Nottingham and Haverhill. Nottingham provides materials characterisation and formulation development expertise that helps customers understand and optimise product performance during development, alongside spray drying and oral solid dose manufacturing capabilities. Haverhill is one of the industry's most established pharmaceutical spray drying facilities, providing commercial-scale manufacturing capabilities backed by extensive operational experience. Together, the two sites create a clear pathway from development and scale-up to commercial manufacture.
Continued investment remains an important part of Codis' growth strategy. Recent investment in the PSD4 spray drying asset at Haverhill, UK further strengthens manufacturing capability and reflects the company's commitment to supporting future customer demand. Combined with established quality systems and manufacturing expertise, the PSD4 enhances Codis' ability to support programmes as they advance towards commercial supply, and offers an exceptional strategic alternative for existing commercial products.
Complementing its UK operations, Codis' US facilities provide advanced particle engineering, granulation, microencapsulation and oral delivery capabilities. The business also offers a portfolio of specialty ingredients and co-processed functional products designed to improve product performance and manufacturability across a range of pharmaceutical, consumer health and nutraceutical applications.
By bringing together formulation development, manufacturing and particle engineering expertise across its global network, Codis provides customers with an integrated approach to solving product and process challenges. Whether supporting development activities, scale-up programmes or long-term commercial supply, Codis is focused on delivering the technical expertise and manufacturing capabilities customers need to bring products to market successfully.
Visit the Codis team at CPHI, Stand 6N4, to learn more about our formulation development, particle engineering, specialty product and commercial manufacturing capabilities.
